| 000 | 01251 a2200349 4500 | ||
|---|---|---|---|
| 005 | 20250514212117.0 | ||
| 264 | 0 | _c20050209 | |
| 008 | 200502s 0 0 eng d | ||
| 022 | _a0006-3002 | ||
| 024 | 7 |
_a10.1016/j.bbcan.2004.09.004 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aO'Neill, Jason | |
| 245 | 0 | 0 |
_aPromises and challenges of targeting Bcl-2 anti-apoptotic proteins for cancer therapy. _h[electronic resource] |
| 260 |
_bBiochimica et biophysica acta _cDec 2004 |
||
| 300 |
_a43-51 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
| 650 | 0 | 4 |
_aApoptosis _xgenetics |
| 650 | 0 | 4 | _aCell Survival |
| 650 | 0 | 4 |
_aGenes, bcl-2 _xgenetics |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aLigands |
| 650 | 0 | 4 |
_aNeoplasms _xgenetics |
| 650 | 0 | 4 |
_aOligonucleotides, Antisense _xtherapeutic use |
| 650 | 0 | 4 |
_aProto-Oncogene Proteins c-bcl-2 _xantagonists & inhibitors |
| 650 | 0 | 4 | _abcl-X Protein |
| 700 | 1 | _aManion, Michael | |
| 700 | 1 | _aSchwartz, Pam | |
| 700 | 1 | _aHockenbery, David M | |
| 773 | 0 |
_tBiochimica et biophysica acta _gvol. 1705 _gno. 1 _gp. 43-51 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.bbcan.2004.09.004 _zAvailable from publisher's website |
| 999 |
_c15269812 _d15269812 |
||